Acute Liver Failure: A Dangerous and Challenging Syndrome

Acute Liver Failure: A Dangerous and Challenging Syndrome

May 27, 2014 at 11:50 AM 0 comments

*Ali Canbay, Guido Gerken Department of Gastroenterology and Hepatology, University Hospital, University Duisburg Essen, Essen, Germany *Correspondence to ali.canbay@uni-due.de Disclosure: No potential conflict of interest. Received: 19.12.13 Accepted: 05.03.14 Citation: EMJ Hepatol. 2014;1:91-98. Abstract Despite progress in understanding the underlying mechanisms, acute liver failure (ALF) is still one of the majorRead More

Liver Transplantation For Alcoholic Liver Disease – Time for a Paradigm Shift?

Liver Transplantation For Alcoholic Liver Disease – Time for a Paradigm Shift?

May 27, 2014 at 11:46 AM 0 comments

*Katharina Staufer, Gabriela Berlakovich Department of Surgery, Division of Transplantation, Medical University of Vienna, Austria *Correspondence to: Katharina.Staufer@meduniwien.ac.at Disclosure: No potential conflict of interest. Received: 07.02.14 Accepted: 27.03.14 Citation: EMJ Hepatol. 2014;1:86-90. Abstract Liver transplantation for alcoholic liver disease (ALD) is controversially discussed. Although overall survival after liver transplantation is similarRead More

Use of HBSAG Quantification To Guide HBIG Prophylaxis After Liver Transplantation

Use of HBSAG Quantification To Guide HBIG Prophylaxis After Liver Transplantation

May 27, 2014 at 11:42 AM 0 comments

*Paolo De Simone,1 Paola Carrai,1 Giulia Leonardi,1 Alessandro Silvestri,1 Davide Ghinolfi,1 Arianna Precisi,2 Daniela Campani,3 and Franco Filipponi1 1. Hepatobiliary Surgery and Liver Transplantation Unit, University of Pisa Medical School Hospital, Pisa, Italy 2. Laboratory, University of Pisa Medical School Hospital, Pisa, Italy 3. Pathology Department, University of Pisa MedicalRead More

Cost-Effective Interventions in The Control of Chronic Hepatitis B (CHB) Infection

Cost-Effective Interventions in The Control of Chronic Hepatitis B (CHB) Infection

May 27, 2014 at 11:37 AM 0 comments

*Mehlika Toy Asian Liver Center and Department of Surgery, Stanford School of Medicine, Stanford; Department of Global Health and Population, Harvard School of Public Health, Boston, USA *Correspondence to mtoy@hsph.harvard.edu Disclosure: No potential conflict of interest. Received: 24.12.13 Accepted: 13.03.14 Citation: EMJ Hepatol. 2014;1:71-76. Abstract The hepatitis B virus (HBV)Read More

Adipose Tissue, Metabolic Syndrome, and Non-Alcoholic Fatty Liver Disease – A Short Review

Adipose Tissue, Metabolic Syndrome, and Non-Alcoholic Fatty Liver Disease – A Short Review

May 27, 2014 at 11:31 AM 0 comments

Panayiotis Kouis, Despina Pampaka, *Andrie G Panayiotou Cyprus International Institute for Environmental and Public Health in association with the Harvard School of Public Health, Cyprus University of Technology, Limassol, Cyprus *Correspondence to andrie.panayiotou@cut.ac.cy Disclosure: No potential conflict of interest. Received: 16.12.2013 Accepted: 27.02.14 Citation: EMJ Hepatol. 2014;1:62-70. Abstract Non-alcoholic fatty liverRead More

Overlapping Clinical Features Between NAFLD and Metabolic Syndrome in Children

Overlapping Clinical Features Between NAFLD and Metabolic Syndrome in Children

May 27, 2014 at 11:26 AM 0 comments

Anna Alisi, *Valerio Nobili Liver Research Unit and Hepato-Metabolic Disease Unit, ‘Bambino Gesù’ Children’s Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy *Correspondence to nobili66@yahoo.it Disclosure: No potential conflict of interest. Received: 05.02.14 Accepted: 19.03.14 Citation: EMJ Hepatol. 2014;1:55-61. Abstract Non-alcoholic fatty liver disease (NAFLD) is aRead More

Translation From Mice to Men: Are Dogs a Dodgy Intermediate?

Translation From Mice to Men: Are Dogs a Dodgy Intermediate?

May 27, 2014 at 11:23 AM 0 comments

Hedwig S. Kruitwagen, Bart Spee, Hille Fieten, Frank G. van Steenbeek, Baukje A. Schotanus, *Louis C. Penning Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, Utrecht University, Yalelaan, Utrecht, the Netherlands *Correspondence to L.C.Penning@uu.nl Disclosure: No potential conflict of interest. Received: 04.02.14 Accepted: 09.04.14 Citation: EMJ Hepatol. 2014;1:48-54. AbstractRead More

News at Six: Hepatitis C Special

News at Six: Hepatitis C Special

May 27, 2014 at 10:41 AM 0 comments

Summary of Presentations from the Bristol Myers Squibb Symposium, held at the 49th Annual EASL ILC, London, UK, on 12th April 2014 Chairperson: Mark Thursz1 Speakers: Jean-Michel Pawlotsky,2 Heiner Wedemeyer,3 Ashley Brown,1 Charles Gore,4 Alessandra Mangia,5 Graham Foster,6 Rafael Esteban7 1. St Mary’s Hospital, London, UK 2. Henri Mondor Hospital, University of Paris-Est, Paris, FranceRead More

Transforming HCV Management

Transforming HCV Management

May 27, 2014 at 10:32 AM 0 comments

Summary of Presentations from the Gilead Sciences (Europe) Symposium, held at the 49th Annual EASL ILC, London, UK, on 9th April 2014 Chairperson: Graham Foster,1 Patrick Marcellin2 Speakers: Ira Jacobson,3 Heiner Wedemeyer,4 Christophe Hézode,5 Antonio Craxì6 1. Queen Mary University of London, London, UK 2. Université Paris-Diderot, Paris, France 3. Weil Cornell Medical College,Read More

Towards a Standardised Method to Acquire and Store Liver Samples and Guidelines to Improve Quality Control and Exchange of Relative Expression Data

Towards a Standardised Method to Acquire and Store Liver Samples and Guidelines to Improve Quality Control and Exchange of Relative Expression Data

December 29, 2013 at 5:51 PM 0 comments

Frank M. Riemers, Jan Rothuizen, Louis C. Penning Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, Utrecht, The Netherlands Disclosure: No potential conflict of interest Citation: EMJ Hepatol. 2013;1:78-84. Abstract The current ‘state-of-the-art’ molecular techniques are extremely sensitive and consequently prone to false results. Even more soRead More